Paris Jonathan 4

What Happened
Jonathan Paris, Chief Legal Officer of Definitive Healthcare Corp. (DH), was granted 481,505 restricted stock units (RSUs) on February 24, 2026. The Form 4 reports the award at an acquisition price of $0.00 (i.e., no cash paid at grant). These RSUs are a compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-24; Form 4 filed: 2026-02-26. Transaction code: A (award/grant).
• Amount granted: 481,505 RSUs; reported acquisition price: $0.00 (no cash paid).
• Vesting schedule (footnote): 25% of the RSUs vest on March 1, 2027, then 6.25% vests every three months thereafter over the next three years (totaling 100% if service continues).
• Shares owned after the transaction: not specified in the supplied filing excerpt.
• Filing timeliness: filed two days after the transaction date (within typical 2-business-day Form 4 timing); no late-filing indication in the provided data.

Context
RSUs represent a contingent right to receive shares upon vesting; they do not transfer tradable shares immediately. This grant is a compensation/retention award rather than a market purchase or sale, so it should be interpreted as a management compensation action rather than a direct buy/sell signal. Tax withholding or share surrender to cover taxes may occur at vesting (not shown in this filing).